Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Sprint Posts Bigger Q2 Loss, Shares Jump

By Christopher Freeburn, InvestorPlace Writer
Sprint posted a larger-than-expected second-quarter loss, but topped revenue estimates and activated 1.5 million iPhones, sending its shares higher.

Natural Gas Finally Shows Some Spark

By Aaron Levitt, InvestorPlace Contributor
Rising demand and falling supplies have prices moving up. It's creating a good opportunity to get into the sector while share prices are still depressed.

AOL Hasn’t Turned the Corner Yet

By Jonathan Berr, InvestorPlace Contributor
A less-awful earnings report has the stock flying. Don't buy it. CEO Tim Armstrong is still talking more than he is delivering on his turnaround plan.

Is It Time to Put RadioShack on Death Watch?

By Marc Bastow, InvestorPlace Assistant Editor
Brick-and-mortar retailer RadioShack suspended its dividend amid a horrid quarter. Is a bankruptcy filing in its near future? Maybe not, if ...

Earnings in the Driver’s Seat — Wednesday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
Apple's earnings weighed on techs and the Nasdaq on Wednesday, while Boeing and Caterpillar helped lift the Dow Jones. After hours, Zynga was getting crushed.

Talk of QE3 Hoists Gold, Silver

By Angela Nazworth, InvestorPlace Writer
Gold and silver prices jumped amid speculation that QE3 lies just around the bend. Rising metal prices and good news from Caterpillar gave wings to miners.

RadioShack Posts Q2 Loss, Suspends Dividend, Shares Plunge

By Christopher Freeburn, InvestorPlace Writer
RadioShack surprised Wall Street analysts by posting a $21 million second-quarter loss, while missing revenue estimates and suspending its dividend.

PepsiCo Tops Estimates on Lower Profit

By Christopher Freeburn, InvestorPlace Writer
Pepsi posted second-quarter earnings down 21% from last year, but still beat Wall Street's forecasts.

Before You Assume the Worst for Vivus …

By James Brumley, InvestorPlace Feature Writer
While there are many reasons to be pessimistic about the future of pharma stock Vivus, the research that has fueled its recent drop is not one of them.

Apple: No Perfect Quarter

By Tom Taulli, InvestorPlace Contributor
The rare earnings and revenue miss was telegraphed, but AAPL shares are dropping anyway. Still, there's some good news, and the price just got more attractive.

Earnings Coaster Dips for Apple — Tuesday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
Earnings news dominated Tuesday's trading, but some of the biggest moves came after the bell, when investors hacked away at AAPL and NFLX.

Gold, Silver Make Marginal Moves Tuesday

By Angela Nazworth, InvestorPlace Writer
Gold and silver prices slid slightly on Tuesday. Miners were more of a mixed bag, though Agnico-Eagle and Eldorado Gold were sparked to life.

Netflix Takes Hit After Earnings

By InvestorPlace Staff
Netflix beat earnings estimates in the second quarter, but shares still couldn't catch a break.

Lockheed Martin Tops Forecasts, Raises Outlook

By Christopher Freeburn, InvestorPlace Writer
Lockheed Martin shook off the prospect of looming cuts in U.S. defense spending to raise its outlook for the year as it topped second-quarter profit estimates.

Lexmark Misses Q2 Estimates, Warns on Q3, Shares Dive

By Christopher Freeburn, InvestorPlace Writer
Lexmark announced second-quarter net income and revenue that fell short of expectations and warned that revenue would decline during the current quarter.

China’s Energy-Buying Binge Is Just Starting

By Aaron Levitt, InvestorPlace Contributor
CNOOC's $15 billion grab of Canada's Nexen means more deals are coming, particularly in Canada. Here are some possibilities for the next to go.

Spain Is an Early Drain: Monday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
Stocks managed to find their footing after a very tough start due to concerns over Spain's ability to avoid default problems.

Gold, Silver Slide; Eldorado Gold Hammered

By Angela Nazworth, InvestorPlace Writer
Gold and silver prices drop Monday, and miners also head lower as analysts get to Eldorado Gold and Silver Wheaton.

Novartis Wins Approval for Breast Cancer Drug

By Christopher Freeburn, InvestorPlace Writer
The FDA has granted approval for Novartis' drug Afinitor to be used as a treatment for breast cancer after it showed promise in clinical trials.
Load More Articles